Northwestern Medicine joins InVivo’s INSPIRE study as clinical site: 5 insights

Cambridge, Mass.-based InVivo Therapeutics added Chicago-based Northwestern Medicine as a clinical site for its INSPIRE study.

Advertisement

Here are five insights:

 

1. Surgeons will execute the study at Northwestern Memorial Hospital, which is an 894-bed Level 1 trauma center.

 

2. Nader Dahdaleh, MD, a neurological surgery assistant professor at Northwestern, will serve as the site’s principal investigator.

 

3. With the addition of Northwestern Medicine, the INSPIRE study now has clinical sites in the top six most populated U.S. cities.

 

4. The INSPIRE study involves 23 clinical sites around the country.

 

5. The INSPIRE study tests the Neuro-Spinal Scaffold’s efficacy and safety for complete thoracic AIS A spinal cord injury.

 

“Chicago, as with other major metropolitan areas, sees a disproportionally high number of acute, traumatic spinal cord injuries and unfortunately, with complete spinal cord injuries, trauma teams have limited tools at their disposal to treat this devastating condition,” said Dr. Dahdaleh.

 

More articles on devices:
3 thoughts on Rotation Medical securing $12 M in series B extension financing
Dr. Paul Favorito publishes findings on special socket component use in shoulder replacement surgery: 3 notes
Spinal Elements’ interspinous process device receives FDA clearance: 5 observations

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.